Eduardo Rodriguez Almaraz

Title(s)SENIOR CRC SUPERVISOR, Neurological Surgery
SchoolSchool of Medicine
Address400 Parnassus Avenue
San Francisco CA 94117
Phone415-514-5529 ext. 45529
ORCID ORCID Icon0000-0003-0978-1117 Additional info
vCardDownload vCard
    Other Positions
    Title(s)UCSF Weill Institute for Neurosciences


    Collapse Biography 
    Collapse Education and Training
    University of California, San Francisco, San FranciscoMAS06/2019Clinical Research
    National Polytechnic Institute, Higher School of MedicineMD11/2012Medicine
    University of California, San Francisco, San FranciscoEpidemiology and Translationa Science

    Collapse Overview 

    Collapse Research 
    Collapse Research Activities and Funding
    Identification of actionable mutations in IDH-mutant gliomas using next generation sequencing (UCSF 500)
    UCSF - Molecular oncology program Aug 1, 2022 - Aug 1, 2023
    Role: Co-investigator
    Sullivan Grant Aug 31, 2020 - Jul 31, 2022
    Impact of Cannabis and synthetic cannabinoid use on quality of life of patients with central nervous system tumors (ICANCNS-QoL)
    Jun 3, 2018
    Role: Co-Investigator

    Collapse ORNG Applications 
    Collapse Featured Publications
    Collapse Collaboration Interests

    Collapse Featured Content 
    Collapse Featured Videos

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. A systematic review and meta-analysis examining the effects of cannabis and its derivatives in adults with malignant central nervous system tumors. A systematic review and meta-analysis examining the effects of cannabis and its derivatives in adults with malignant central nervous system tumors. 2020; (7). Jesus-Eduardo Rodriguez-Almaraz, MD, MAS, Susan Chang, MD, Jennifer Clarke, MD, MPH, Nancy Ann Oberheim-Bush, MD, PhD, Jennie Taylor, MD, Robin Buerki, MD, Mitchell Berger, MD, Lydia Zablotska, MD, PhD, Iryna Lobach, PhD, Nicholas Butowski, MD. View Publication.
    2. PI3K/mTOR Pathway Activation Selected Phase II Study of Everolimus (RAD001) with and without Temozolomide in the treatment of Adult Patients with supratentorial low-grade glioma. 2019; 21(Supp_6):vi22-vi23. Jennie Taylor, Annette Molinaro, Eduardo Rodriguez Almaraz, Ciara Downey, Joanna Phillips, Nancy Ann Oberheim-Bush, Nicholas Butowski, Susan Chang, Mitchel Berger, Michael Prados, Daphne Haas-Kogan, Jennifer Clarke. View Publication.
    3. Impact of cannabis use on quality of life in patients with central nervous system tumors. 2019; 21(Supp_3):iii37. J E Rodriguez Almaraz, S M Chang, N A E Oberheim-Bush, J R Clarke, J W Taylor, R A Buerki, M S Berger, N A Butowski. View Publication.
    4. Clinical experi- ence with short-term-combined formula as pharmacological treatment (extended release) in the man- agement of obesity. Clinical experi- ence with short-term-combined formula as pharmacological treatment (extended release) in the man- agement of obesity. 2014; 3(81). Morin-Zaragoza R, Rodrguez-Choreo JD, Morales-Surez MO, Rodrguez-Almaraz JE. View Publication.
    5. Mexican Contributions to the study of Obesity. Pharmacology chapter. 2014. Leija, Gerardo.
    6. Possible mechanisms involved in the vasorelaxant effect produced by fenproporex in aortic segments of rats. 2013. Lopez-Canales JS, Lozano-Cuenca J, Morin-Zaragoza R, Rodriguez-Almaraz JE. View Publication.
    Same Department
    Search Department
    _

    UCSF Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).
    This site is running Profiles RNS version v3.1.0-871-g21b54b14 on PROFILES-PWEB01.

    Copyright © The Regents of the University of California